This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Effect of Alteplase vs No alteplase on mRS 3-6 at 90 days in Stroke 0-3 hours prior
{ "resourceType": "Evidence", "id": "example-stroke-0-3-alteplase-vs-no-alteplase-mRS3-6", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p>\n "Effect of Alteplase vs No alteplase on mRS 3-6 at 90 days in Stroke 0-3 hours prior" is a comparative effect estimate.\n </p>\n\t</div>" }, "url": "Evidence/example-stroke-0-3-alteplase-vs-no-alteplase-mRS3-6", "title": "Effect of Alteplase vs No alteplase on mRS 3-6 at 90 days in Stroke 0-3 hours prior", "status": "draft", "relatedArtifact": [ { "type": "citation", "label": "Wardlaw 2014", "display": "Analysis 1.16 from Wardlaw 2014", "citation": "Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014 Jul 29(7):CD000213. PMID 25072528", "url": "https://doi.org/10.1002/14651858.CD000213.pub3" } ], "description": "mRS 3-6 at 90 days Odds Ratio 0.65 for Alteplase vs. No Alteplase in patients with acute ischemic stroke 0-3 hours prior", "variableDefinition": [ { "variableRole": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/variable-role", "code": "population", "display": "population" } ] }, "observed": { "reference": "EvidenceVariable/Wardlaw2014Analysis1.16.3EvidenceSet", "type": "EvidenceVariable", "display": "Wardlaw 2014 Analysis 1.16.3 Evidence set" }, "intended": { "reference": "Group/AcuteIschemicStroke0-3Hours", "type": "Group", "display": "stroke at 0-3 hours" } }, { "variableRole": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/variable-role", "code": "measuredVariable", "display": "measured variable" } ] }, "observed": { "reference": "EvidenceVariable/example-mRS3-6-at-90days", "type": "EvidenceVariable", "display": "mRS 3-6 at 90 days" }, "intended": { "reference": "EvidenceVariable/example-dead-or-dependent-90day", "type": "EvidenceVariable", "display": "Dead or functionally dependent at 90 days" } }, { "variableRole": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/variable-role", "code": "exposure", "display": "exposure" } ] }, "observed": { "reference": "EvidenceVariable/example-alteplase-for-stroke", "type": "EvidenceVariable", "display": "Alteplase for Stroke" }, "intended": { "reference": "EvidenceVariable/example-alteplase-for-stroke", "type": "EvidenceVariable", "display": "Alteplase for Stroke" } }, { "variableRole": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/variable-role", "code": "referenceExposure", "display": "reference exposure" } ] }, "observed": { "reference": "EvidenceVariable/example-no-alteplase", "type": "EvidenceVariable", "display": "no alteplase" }, "intended": { "reference": "EvidenceVariable/example-no-alteplase", "type": "EvidenceVariable", "display": "no alteplase" } } ], "synthesisType": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/synthesis-type", "code": "std-MA", "display": "summary data meta-analysis" } ] }, "studyType": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/study-type", "code": "RCT", "display": "randomized trial" } ] }, "statistic": [ { "statisticType": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/statistic-type", "code": "C16932", "display": "Odds Ratio" } ] }, "quantity": { "value": 0.65 }, "numberOfEvents": 1137, "sampleSize": { "numberOfStudies": 6, "numberOfParticipants": 1779 }, "attributeEstimate": [ { "description": "95% CI 0.54 to 0.80", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type", "code": "C53324", "display": "Confidence interval" } ] }, "level": 0.95, "range": { "low": { "value": 0.54 }, "high": { "value": 0.8 } } }, { "description": "P-value = 0.000023", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type", "code": "C44185", "display": "P-value" } ] }, "quantity": { "value": 0.000023 } }, { "description": "Heterogeneity I-sq = 0.0%", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type", "code": "0000420", "display": "I-squared" } ] }, "quantity": { "value": 0, "unit": "%", "system": "http://unitsofmeasure.org", "code": "%" } } ] } ], "certainty": [ { "description": "Moderate certainty due to risk of bias", "rating": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/evidence-quality", "code": "moderate", "display": "Moderate" } ] } ], "certaintySubcomponent": [ { "type": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-type", "code": "PublicationBias", "display": "Publication bias" } ] } ], "rating": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating", "code": "no-concern", "display": "no serious concern" } ] } ] }, { "type": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-type", "code": "Inconsistency", "display": "Inconsistency" } ] } ], "rating": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating", "code": "no-concern", "display": "no serious concern" } ] } ] }, { "type": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-type", "code": "Imprecision", "display": "Imprecision" } ] } ], "rating": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating", "code": "no-concern", "display": "no serious concern" } ] } ] }, { "type": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-type", "code": "Indirectness", "display": "Indirectness" } ] } ], "rating": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating", "code": "no-concern", "display": "no serious concern" } ] } ] }, { "note": [ { "text": "results largely influenced by IST-3 trial which was unblinded and NINDS trial which had allocation concealment not stated and baseline imbalances" } ], "type": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-type", "code": "RiskOfBias", "display": "Risk of bias" } ] } ], "rating": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating", "code": "serious-concern", "display": "serious concern" } ] } ] } ] } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.